Literature DB >> 21859935

Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli.

Sally R Partridge1, Zhiyong Zong, Jonathan R Iredell.   

Abstract

CTX-M-15 now appears to be the dominant extended-spectrum β-lactamase worldwide, and a number of different factors may contribute to this success. These include associations between bla(CTX-M-15) and particular plasmids (IncF) and/or strains, such as Escherichia coli ST131, as well as the genetic contexts in which this gene is found. We previously identified bla(CTX-M-15) as the dominant ESBL gene in the western Sydney area, Australia, and found that it was carried mainly on IncF or IncI1 plasmids. Here, we have mapped the multiresistance regions of the 11 conjugative plasmids with one or more IncF replicons obtained from that survey and conducted a limited comparison of plasmid backbones. Two plasmids with only an IncFII replicon appear to be very similar to the published plasmids pC15-1a and pEK516. The remaining nine plasmids, with multiple IncF replicons, have multiresistance regions related to those of pC15-1a and pEK516, but eight contain additional modules previously found in resistance plasmids from different geographic locations that carry a variety of different resistance genes. Differences between the multiresistance regions are largely due to IS26-mediated deletions, insertions, and/or rearrangements, which can explain the observed variable associations between bla(CTX-M-15) and certain other resistance genes. We found no evidence of independent movement of bla(CTX-M-15) or of a large multiresistance region between different plasmid backbones. Instead, homologous recombination between common components, such as IS26 and Tn2, appeared to be more important in creating new multiresistance regions, and this may be coupled with recombination in plasmid backbones to reassort multiple IncF replicons as well as components of multiresistance regions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859935      PMCID: PMC3195058          DOI: 10.1128/AAC.00025-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  47 in total

1.  Mosaic plasmids and mosaic replicons: evolutionary lessons from the analysis of genetic diversity in IncFII-related replicons.

Authors:  A Mark Osborn; Fernanda M da Silva Tatley; Lafras M Steyn; Roger W Pickup; Jon R Saunders
Journal:  Microbiology (Reading)       Date:  2000-09       Impact factor: 2.777

Review 2.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene.

Authors:  Laurent Poirel; Jean-Winoc Decousser; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 4.  From pieces to patterns: evolutionary engineering in bacterial pathogens.

Authors:  Fernando Baquero
Journal:  Nat Rev Microbiol       Date:  2004-06       Impact factor: 60.633

5.  Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants.

Authors:  Laura Villa; Aurora García-Fernández; Daniela Fortini; Alessandra Carattoli
Journal:  J Antimicrob Chemother       Date:  2010-10-08       Impact factor: 5.790

6.  Regional survey of CTX-M-type extended-spectrum β-lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone.

Authors:  Li Xu; Sahida Shabir; Thomas Bodah; Claire McMurray; Katie Hardy; Peter Hawkey; Kathryn Nye
Journal:  J Antimicrob Chemother       Date:  2010-12-23       Impact factor: 5.790

Review 7.  Analysis of antibiotic resistance regions in Gram-negative bacteria.

Authors:  Sally R Partridge
Journal:  FEMS Microbiol Rev       Date:  2011-06-16       Impact factor: 16.408

8.  RSF1010-like plasmids in Australian Salmonella enterica serovar Typhimurium and origin of their sul2-strA-strB antibiotic resistance gene cluster.

Authors:  Sheree Yau; Xiulan Liu; Steven P Djordjevic; Ruth M Hall
Journal:  Microb Drug Resist       Date:  2010-07-09       Impact factor: 3.431

9.  Distribution of the blaTEM gene and blaTEM-containing transposons in commensal Escherichia coli.

Authors:  Jannine K Bailey; Jeremy L Pinyon; Sashindran Anantham; Ruth M Hall
Journal:  J Antimicrob Chemother       Date:  2011-01-20       Impact factor: 5.790

10.  Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital.

Authors:  Véronique Leflon-Guibout; Cécile Jurand; Stéphane Bonacorsi; Florence Espinasse; Marie Claude Guelfi; Françoise Duportail; Beate Heym; Edouard Bingen; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more
  35 in total

1.  pJIE137 carrying blaCTX-M-62 is closely related to p271A carrying blaNDM-1.

Authors:  Sally R Partridge; Ian T Paulsen; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

2.  Complete sequence of pJIE143, a pir-type plasmid carrying ISEcp1-blaCTX-M-15 from an Escherichia coli ST131 isolate.

Authors:  Sally R Partridge; Justin A Ellem; Sasha G Tetu; Zhiyong Zong; Ian T Paulsen; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

3.  Complete nucleotide sequences of bla(CTX-M)-harboring IncF plasmids from community-associated Escherichia coli strains in the United States.

Authors:  Jun-Jie Li; Caressa N Spychala; Fupin Hu; Ji-Fang Sheng; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

4.  Genetic contexts of blaNDM-1.

Authors:  Sally R Partridge; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2012-11       Impact factor: 5.191

5.  pEl1573 Carrying blaIMP-4, from Sydney, Australia, is closely related to other IncL/M plasmids.

Authors:  Sally R Partridge; Andrew N Ginn; Ian T Paulsen; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

6.  Characterization of IncI1 sequence type 71 epidemic plasmid lineage responsible for the recent dissemination of CTX-M-65 extended-spectrum β-lactamase in the Bolivian Chaco region.

Authors:  Eleonora Riccobono; Vincenzo Di Pilato; Tiziana Di Maggio; Carmen Revollo; Alessandro Bartoloni; Lucia Pallecchi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

7.  Contribution of IncFII and broad-host IncA/C and IncN plasmids to the local expansion and diversification of phylogroup B2 Escherichia coli ST131 clones carrying blaCTX-M-15 and qnrS1 genes.

Authors:  Ângela Novais; Diana Viana; Fernando Baquero; Javier Martínez-Botas; Rafael Cantón; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

8.  Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010).

Authors:  Angela Novais; João Pires; Helena Ferreira; Luísa Costa; Carolina Montenegro; Claudia Vuotto; Gianfranco Donelli; Teresa M Coque; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

9.  Complete sequence of pJIE186-2, a plasmid carrying multiple virulence factors from a sequence type 131 Escherichia coli O25 strain.

Authors:  Zhiyong Zong
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

10.  Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.

Authors:  Bente Olesen; Dennis S Hansen; Frida Nilsson; Jakob Frimodt-Møller; Rikke Fleron Leihof; Carsten Struve; Flemming Scheutz; Brian Johnston; Karen A Krogfelt; James R Johnson
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.